Zobrazeno 1 - 10
of 167
pro vyhledávání: '"Thomas, Delate"'
Autor:
Carrie P. Wong, Thomas Delate, Elizabeth Hudson, Julia K. Nguyen, Su-Jau Yang, Mariana Abraham
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Urinary tract infections (UTI) are often over-diagnosed and over-treated, which can induce and select for resistant pathogens. After observing wide-spread outpatient use of ertapenem, a broad-spectrum antibiotic, a structured anti
Externí odkaz:
https://doaj.org/article/53e52a1313e0401598b75766f7a660e3
Publikováno v:
The Permanente Journal. :1-10
Autor:
Lauren Cline, Erika Marie G. Generoso, Nicholas D’Apice, Sara K. Dellinger, Amber Tovey, Nathan P. Clark, Fang Nui, Rita Hui, Stephanie A. Hale, Tanya Ramsey, Kimi Pontoppidan, Hasmig Ekmekdjian, Kristen Fink, Daniel M. Witt, Mark A. Crowther, Thomas Delate
Publikováno v:
Journal of Thrombosis and Thrombolysis. 55:355-364
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231100 (2020)
BACKGROUND:Elective percutaneous coronary interventions (PCI) are difficult to discriminate from non-elective PCI in administrative data due to non-specific encounter codes, limiting the ability to track outcomes, ensure appropriate medical managemen
Externí odkaz:
https://doaj.org/article/2b8d0ebdd67e489ca045af76ef7df41d
Autor:
Catherine G Derington, Jordan B King, Thomas Delate, Sheila R Botts, Miranda Kroehl, David P Kao, Katy E Trinkley
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243371 (2020)
BackgroundLisinopril and losartan manufacturer labels recommend twice-daily dosing (BID) if once-daily (QDay) is insufficient to lower blood pressure (BP).Methods and resultsRetrospective cohort study of patients taking QDay lisinopril and losartan w
Externí odkaz:
https://doaj.org/article/e08f8dcbeafa44a58d3e9961c141a874
Autor:
Lauren, Cline, Erika Marie G, Generoso, Nicholas, D'Apice, Sara K, Dellinger, Amber, Tovey, Nathan P, Clark, Fang, Nui, Rita, Hui, Stephanie A, Hale, Tanya, Ramsey, Kimi, Pontoppidan, Hasmig, Ekmekdjian, Kristen, Fink, Daniel M, Witt, Mark A, Crowther, Thomas, Delate
Publikováno v:
Journal of thrombosis and thrombolysis.
The few studies that compared direct oral anticoagulants (DOAC) vs. warfarin in the setting of advanced renal insufficiency have focused on patients with atrial fibrillation. The purpose of this observational, matched, cohort study of patients was to
Autor:
James D. Ralston, Andrew L. Berry, Richard W. Grant, Jennifer Barrow, Thomas Delate, Kathy Gleason, Marlaine Figueroa Gray, Leah Tuzzio, Connie S. Uratsu, Zoë A. Bermet, Elizabeth A. Bayliss
Publikováno v:
Health Serv Res
Objective To identify opportunities to align care with the personal values of patients from three distinct groups with complex medical, behavioral, and social needs. Data sources/study setting Between June and August 2019, we conducted semi-structure
Publikováno v:
Family Practice. 38:623-629
Background While use of glucagon-like peptide-1 (GLP-1) agonists and sodium-glucose cotransporter-2 (SGLT-2) inhibitors reduces the risk of atherosclerotic cardiovascular disease outcomes and lowers glycosylated haemoglobin (A1C), evidence on patient
Autor:
Jackson King, Ashok Pai, Nathan P. Clark, Daniel M. Witt, Thomas Delate, Malti Charlu, Shiyun Zhu, Jordan B. King
Publikováno v:
Thrombosis Research. 196:367-370
Background First-line treatment and secondary prevention of venous thromboembolism (VTE) in patients with cancer consisted, historically, of unfractionated heparin or low-molecular weight heparin (LMWH). With recent clinical trials of direct oral ant
Publikováno v:
Blood. 140:5668-5669